BDR Pharma launches Bdenza 160 mg for treatment of prostate cancer
Another first time ever launch of Enzalutamide 160 mg in BDR Pharma's basket was awaited by many Indian oncologists
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.